Companies: 10,795·Total market cap: $144.5T
Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc.

TMCINASDAQHealthcare● Active
$3.53
+$0.02(+0.57%)
Market Cap$229001605
P/E Ratio
52W High$7.78
52W Low$1.17
Overview

Treace Medical Concepts, Inc. (TMCI) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · TMCI · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.97tmci eps ttm · tmci earnings per shareEarnings history
PE Ratio (TTM)tmci pe ratio ttm · tmci price to earningsPE Ratio deep dive
Revenue (TTM)$207.3Mtmci revenue ttm · tmci annual revenueFull revenue history
Dividend YieldNo Dividenddoes tmci pay dividends · tmci dividend yieldDividend history
Shares Outstanding63.3Mtmci shares outstanding · tmci floatShares outstanding history
Next EarningsAug 6, 2026Est.tmci earnings date · tmci next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$212.7M▲ +1.59% YoY
202320242025
treace medical concepts, inc. revenue · tmci revenue 2025
FY 2025Net Income-$59.0M▼ 5.85% YoY
202320242025
treace medical concepts, inc. net income · tmci profit 2025
FY 2025EPS$-0.93▼ 3.33% YoY
202320242025
tmci eps · treace medical concepts, inc. earnings per share 2025
TTM:Revenue: $207.3MNet Income: -$61.0MEPS: $-0.97View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold9 analystsis tmci a buy · tmci analyst rating
Strong Buy
0
Buy
2
Hold
6
Sell
1
Strong Sell
0
12-Month Price Target
$3.00Low
$3.53Current
$3.00Avg Target15.01% downside
$3.00High
tmci price target · tmci 12 month forecast

Total: 9 · Buy rate: 22.2%

The TMCI analyst consensus is Hold, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $3.00, representing -15.01% downside from the current price of $3.53.

Stock Performance

Full History
1D+1.85%
1W+5.15%
1M+77.86%
3M+150.00%
YTD+45.92%
1Y-39.41%
5Y-90.06%

About Treace Medical Concepts, Inc.

CEOJohn T. Treace
IPO DateApr 23, 2021
Employees477
CountryUS
Websitetreace.com

Treace Medical Concepts, Inc. Headquartered in Ponte Vedra Beach, Florida, Treace Medical Concepts, Inc. is an orthopedic medical device enterprise that specializes in the development, manufacturing, and commercialization of surgi…

what is treace medical concepts, inc. · tmci stock overview · treace medical concepts, inc. company profile · who is treace medical concepts, inc. ceo · tmci NASDAQ · treace medical concepts, inc. headquarters · treace medical concepts, inc. business segments

About Stock Overview & Key Data

Treace Medical Concepts, Inc. (TMCI) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Apr 23, 2021. As of the latest trading session, TMCI stock price is $3.53, with a market capitalization of $229.0M. The stock has returned -39.41% over the past 12 months and +45.92% year-to-date.

According to 9 Wall Street analysts, the consensus rating for Treace Medical Concepts, Inc. stock is Hold, with an average 12-month price target of $3.00. In fiscal year 2025, Treace Medical Concepts, Inc. reported revenue of $212.7M and net income of -$59.0M. For detailed data — including Treace Medical Concepts, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Treace Medical Concepts, Inc. (TMCI) stock price is $3.53. The stock is traded on NASDAQ under the ticker symbol TMCI. The 52-week range is $1.17 – $7.78.

TMCI stock priceTMCI quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice